Administrative Core
Administrative Core
批准号:
10468802
负责人:
Steven Mark Rowe
金额:
$10.31万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2023-04-30
关键词:
Advisory CommitteesAreaAwardBiologyBiomedical ResearchBusinessesCareer MobilityCellsClinical SciencesCollaborationsCommunicationCommunitiesComplementCore FacilityCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDevelopmentDiabetes MellitusEnvironmentEquipmentEvaluationFacultyFosteringFundingGoalsGrantGrowthHuman ResourcesInstitutionInterdisciplinary StudyInvestmentsLeadershipMedicineMonitorMusNational Institute of Diabetes and Digestive and Kidney DiseasesNewsletterObesityParticipantPharmaceutical PreparationsPositioning AttributeProceduresProductivityRattusRecommendationResearchResearch PersonnelResearch TrainingResourcesScienceScientistSiteSite VisitStudentsSystemTechnologyTrainingTranslational ResearchTranslationsUnited States National Institutes of HealthUtilization ReviewWritingbasecareercareer developmentclinical centerexperienceinnovationinnovative technologiesinventionmeetingsmembernext generationnovelnutritionoperationpediatric departmentprogramsranpirnasesuccesssymposiumsynergismweb site
中文摘要
项目总结/摘要
UAB囊性纤维化研究和翻译核心中心行政核心是
负责生物医学研究中心的整体管理和协调,
试点和可行性方案以及浓缩方案。导演:Drs. Rowe(P01导演)
Bedwell(副主任)在经验丰富的研究管理人员的协助下,
行政团队-包括中心业务官Jamie Elliot女士和艾米丽福尔克博士-
Libby,科学事务项目总监-核心将继续成功支持CF
中心在即将到来的资助周期中的目标是:1)建立以下方面的总体科学方向:
UAB P30 CF中心(例如,指挥管理核心P01之间的通信
调查人员,中心内部咨询委员会的成员,和/或外部
外部咨询委员会的顾问审查中心的活动,并确定研究
方向和机会),2)促进所有P30组成部分的目标(例如,
优化核心资源,以实现最佳利用,协调培训和专业
发展活动,维护中心网站,监督会员,
生物医学核心研究基地和监测其生产力),以及3)整合P30
与其他UAB NIH中心的组件(例如,促进和分享其创新资源
并与其他中心领导层沟通,如临床中心和
转化科学(UAB的CTSA网站),NIDDK糖尿病研究和培训中心,以及
NIDDK-营养肥胖研究中心),以确定持续的机会,
多学科合作。此外,特别是为了支持该中心的丰富和
试点和可行性方案,行政核心将继续确定和整合
通过机构提供的资源,以最大限度地提高学员的成功和过渡到
初级教师的独立性,以及应用其既定的,强大的机制,
征求、审查和监督P30试点应用程序,以促进新的和重要的
对CF科学的贡献。总的来说,行政核心的目标是以最佳方式
促进CF P30中心的协同作用和进步。
英文摘要
PROJECT SUMMARY/ABSTRACT
The UAB Cystic Fibrosis Research and Translation Core Center Administrative Core is
responsible for the overall administration and coordination of the Biomedical Research Cores,
Pilot & Feasibility Program, and Enrichment Program. Directed by Drs. Rowe (P01 Director) and
Bedwell (Associate Director) with assistance from the experienced Research Management and
Administrative Team—including Ms. Jamie Elliot, Center Business Officer and Dr. Emily Falk-
Libby, Program Director-Scientific Affairs—the Core will continue to successfully support CF
Center goals in the upcoming funding cycle by: 1) Establishing the overall scientific direction of
the UAB P30 CF Center (e.g., directing communications between the Administrative Core, P01
investigators, members of the Center's active Internal Advisory Board, and/or external
consultants on its External Advisory Board to review Center activities and identify research
directions and opportunities), 2) Facilitating the objectives of all P30 components (e.g.,
optimizing Core resources for optimal utilization, coordinating training and professional
development activities, maintaining a Center website, overseeing membership, building the
Biomedical Core research base and monitoring its productivity), and 3) Integrating P30
components with other UAB NIH Centers (e.g., promoting and sharing its innovative resources
and communicating with other Center leadership such as the Center for Clinical and
Translational Science (UAB's CTSA site), NIDDK-Diabetes Research and Training Center, and
NIDDK-Nutrition Obesity Research Center) to identify continued opportunities for
multidisciplinary collaboration. In addition, specifically in support of the Center's Enrichment and
Pilot & Feasibility Programs, the Administrative Core will continue to identify and integrate
resources offered through the Institution to maximize trainee success and transition to
independence for junior faculty as well as to apply its established, robust mechanisms for
solicitation, review, and oversight of P30 pilot applications to foster new and important
contributions to CF science. Overall, it is the goal of the Administrative Core to optimally
promote synergy and progress within the CF P30 Center.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UAB U-SPECT6CTUHROI Imager
-
批准号:10177258
-
项目类别:
-
资助金额:$75.0万
-
财政年份:2021
-
负责人:Steven Mark Rowe
-
依托单位:
Therapeutic targeting of MUC5B in a novel ferret model of idiopathic pulmonary fibrosis
-
批准号:10318909
-
项目类别:
-
资助金额:$59.29万
-
财政年份:2020
-
负责人:Steven Mark Rowe
-
依托单位:
Therapeutic targeting of MUC5B in a novel ferret model of idiopathic pulmonary fibrosis
-
批准号:10529294
-
项目类别:
-
资助金额:$56.93万
-
财政年份:2020
-
负责人:Steven Mark Rowe
-
依托单位:
Therapeutic targeting of MUC5B in a novel ferret model of idiopathic pulmonary fibrosis
-
批准号:10026575
-
项目类别:
-
资助金额:$46.23万
-
财政年份:2020
-
负责人:Steven Mark Rowe
-
依托单位:
Translational Program in CFTR-Related Airway Diseases
-
批准号:9244375
-
项目类别:
-
资助金额:$93.01万
-
财政年份:2017
-
负责人:Steven Mark Rowe
-
依托单位:
Translational Program in CFTR-Related Airway Diseases
-
批准号:10225226
-
项目类别:
-
资助金额:$82.59万
-
财政年份:2017
-
负责人:Steven Mark Rowe
-
依托单位:
Translational Program in CFTR-Related Airway Diseases
-
批准号:10462476
-
项目类别:
-
资助金额:$91.8万
-
财政年份:2017
-
负责人:Steven Mark Rowe
-
依托单位:
Functional Anatomic Imaging of CF Patients with Early Lung Disease Using microOCT
-
批准号:8550128
-
项目类别:
-
资助金额:$53.88万
-
财政年份:2012
-
负责人:Steven Mark Rowe
-
依托单位:
Functional Anatomic Imaging of CF Patients with Early Lung Disease Using microOCT
-
批准号:8690962
-
项目类别:
-
资助金额:$49.8万
-
财政年份:2012
-
负责人:Steven Mark Rowe
-
依托单位:
Functional Anatomic Imaging of CF Patients with Early Lung Disease Using microOCT
-
批准号:8410983
-
项目类别:
-
资助金额:$50.02万
-
财政年份:2012
-
负责人:Steven Mark Rowe
-
依托单位:
Molecular Pathogenesis and Phenotype of Acquired CFTR Dysfunction in COPD
-
批准号:8021745
-
项目类别:
-
资助金额:$36.76万
-
财政年份:2011
-
负责人:Steven Mark Rowe
-
依托单位:
Molecular Pathogenesis and Phenotype of Acquired CFTR Dysfunction in COPD
-
批准号:8437182
-
项目类别:
-
资助金额:$33.1万
-
财政年份:2011
-
负责人:Steven Mark Rowe
-
依托单位:
Molecular Pathogenesis and Phenotype of Acquired CFTR Dysfunction in COPD
-
批准号:8843207
-
项目类别:
-
资助金额:$5.25万
-
财政年份:2011
-
负责人:Steven Mark Rowe
-
依托单位:
Molecular Pathogenesis and Phenotype of Acquired CFTR Dysfunction in COPD
-
批准号:8225231
-
项目类别:
-
资助金额:$36.06万
-
财政年份:2011
-
负责人:Steven Mark Rowe
-
依托单位:
Molecular Pathogenesis and Phenotype of Acquired CFTR Dysfunction in COPD
-
批准号:8605905
-
项目类别:
-
资助金额:$36.81万
-
财政年份:2011
-
负责人:Steven Mark Rowe
-
依托单位:
Molecular Pathogenesis and Phenotype of Acquired CFTR Dysfunction in COPD
-
批准号:8791330
-
项目类别:
-
资助金额:$44.69万
-
财政年份:2011
-
负责人:Steven Mark Rowe
-
依托单位:
Mechanistic Basis Underlying Protein Repair of CFTR Nonsense Mutations
-
批准号:7706429
-
项目类别:
-
资助金额:$7.32万
-
财政年份:2009
-
负责人:Steven Mark Rowe
-
依托单位:
Mechanistic Basis Underlying Protein Repair of CFTR Nonsense Mutations
-
批准号:7920196
-
项目类别:
-
资助金额:$7.25万
-
财政年份:2009
-
负责人:Steven Mark Rowe
-
依托单位:
Core C- Clinical and Translational Core
-
批准号:10468806
-
项目类别:
-
资助金额:$22.65万
-
财政年份:2007
-
负责人:Steven Mark Rowe
-
依托单位:
UAB CF Research and Translation Core Center
-
批准号:10246443
-
项目类别:
-
资助金额:$111.37万
-
财政年份:2007
-
负责人:Steven Mark Rowe
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: